Konstantin Adamsky
Directeur/Bestuurslid bij FILAMENT HEALTH CORP.
Profiel
Konstantin Adamsky is currently the Chief Executive Officer at Negev Labs and an Independent Director at Filament Health Corp.
He previously worked as the Co-Chief Executive Officer & Director at Targia Pharmaceuticals Ltd.
in 2016, Vice President-Operations at Regenera Pharma Ltd.
from 2017 to 2020, and as VP Operations & Technology at Levco Pharmaceuticals Ltd.
He holds a doctorate degree from the Weizmann Institute of Science.
Actieve functies van Konstantin Adamsky
| Bedrijven | Functie | Begin |
|---|---|---|
| FILAMENT HEALTH CORP. | Directeur/Bestuurslid | 23-08-2022 |
Eerdere bekende functies van Konstantin Adamsky
| Bedrijven | Functie | Einde |
|---|---|---|
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Algemeen Directeur | 01-08-2017 |
| Levco Pharmaceuticals Ltd. | Operationeel Directeur | - |
Opleiding van Konstantin Adamsky
| Weizmann Institute of Science | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FILAMENT HEALTH CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
| Levco Pharmaceuticals Ltd. |
